Medical Science Liaison, Cell Therapy (Kentucky and Tennessee) at Bristol-Myers Squibb

Nashville, Tennessee, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Field-based role requiring majority of time interacting with external stakeholders (e.g., investigators, clinical thought leaders) in Kentucky and Tennessee territory
  • High level of therapeutic expertise in cell therapy
  • Ability to capture medical insights and act as clinical & scientific advisor to cross-functional partners
  • Alignment of interactions with enterprise and medical strategies
  • Focus on pre- and peri-launch activities or lifecycle needs of the brand
  • Engagement in educational dialogue with HCPs, sharing relevant clinical evidence based on physicians’ needs and field medical plan
  • Support for internal stakeholders

Responsibilities

  • Effectively collaborate and engage in scientific dialogue with Thought Leaders (TLs) to gain insights on clinical landscape and develop product/disease area-focused medical plan for effective launch
  • Proactively engage in scientific and clinical conversations to support launch and lifecycle management (LCM) activities
  • Engage with medical societies, Patient Advocacy Groups (PAGs), and guideline committee members as appropriate
  • Provide training for external speakers as needed
  • Strategically engage payers in pre- and peri-launch phases (with fHEOR and Account Executives)
  • Provide medical support to address unsolicited HCP questions in real-time (face-to-face or via Medical on Call)
  • Develop credible connections with key Thought Leaders in the therapeutic area through high-quality peer-to-peer scientific dialogue
  • Appropriately document and achieve annual goals
  • Leverage digital capabilities to enhance medical engagement
  • Provide recommendations and insights to clinical development team on study feasibilities based on field knowledge and investigator contacts
  • Liaise with key large accounts to understand clinical barriers to patient access and ensure equity in access to clinical trials
  • Lead major evidence read-outs with clinical trial investigators (e.g., Phase 3 top-line data)
  • Support Interventional and Non-Interventional Research (NIR) studies (e.g., identification and assessment of potential study sites) to facilitate patient recruitment and discussions on safe and effective use

Skills

Key technologies and capabilities for this role

Cell TherapyMedical Science LiaisonClinical EvidenceHCP EngagementScientific CommunicationMedical StrategyField MedicalPre-Launch ActivitiesLifecycle ManagementInvestigator Interactions

Questions & Answers

Common questions about this position

What is the work arrangement for this Medical Science Liaison role?

This is a field-based role where the employee will spend a majority of the time in the field interacting with external stakeholders in the Kentucky and Tennessee territory, while also supporting internal stakeholders.

What benefits does Bristol Myers Squibb offer?

Bristol Myers Squibb offers a wide variety of competitive benefits, services, and programs that provide employees with resources to pursue their goals both at work and in their personal lives.

What is the salary for this position?

This information is not specified in the job description.

What skills are needed for the Cell Therapy MSL role?

The role requires strong skills in scientific dialogue, collaboration with thought leaders (TLs), engagement with HCPs, medical societies, PAGs, and payers, as well as providing training and real-time medical support.

What is the company culture like at Bristol Myers Squibb?

The culture is challenging, meaningful, and life-changing, with uniquely interesting work, opportunities to grow and thrive alongside high-achieving teams, and an emphasis on balance and flexibility.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI